Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults
Open Access
- 28 August 2023
- journal article
- research article
- Published by S. Karger AG in Obesity Facts
- Vol. 16 (6) , 548-558
Abstract
Introduction: The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) with renal insufficiency in recent years and the association between MAFLD and renal insufficiency are not entirely clear, especially in overweight/obesity. The aim of this study was to analyze the prevalence and risk factors of MAFLD with renal insufficiency in overweight/obese adults. Methods: Individuals who attended checkup at the Second Affiliated Hospital of Xi’an Jiaotong University from 2016 to 2021 were included. The prevalence of MAFLD with renal insufficiency (estimated glomerular filtration rate ≤90 mL/min/1.73 m2) in overweight/obesity was estimated. Propensity score-matched analysis, univariate and multivariate analyses were used to determine the risk factors for MAFLD with renal insufficiency. Results: From 2016 to 2021, the prevalence of MAFLD in overweight/obesity reached its highest of 44.7% in 2017 and its lowest of 36.9% in 2018; and 33.9% in 2021 and 21.8% in 2019 is the highest and lowest prevalence of MAFLD with renal insufficiency, respectively. MAFLD was more common in men, old individuals, and persons with a higher body mass index (BMI) and was characterized by significant renal insufficiency. MAFLD with renal insufficiency was more common in women, old individuals, and persons with a higher BMI and was characterized by significant metabolic dysfunction and liver fibrosis. Multivariable analysis showed that BMI, uric acid, and fibrosis (evaluated with noninvasive liver fibrosis score [fibrosis-4]) were independent risk factors for MAFLD with renal insufficiency. Conclusion: The prevalence of MAFLD with renal insufficiency in overweight/obese adults is quite high in the last 5 years. BMI, uric acid, and fibrosis are independent risk factors for MAFLD with renal insufficiency.Keywords
This publication has 34 references indexed in Scilit:
- Mechanisms of NAFLD development and therapeutic strategiesNature Medicine, 2018
- Obesity as a DiseaseMedical Clinics of North America, 2018
- Health Effects of Overweight and Obesity in 195 Countries over 25 YearsNew England Journal of Medicine, 2017
- ObesityNature Reviews Disease Primers, 2017
- Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeInternational Journal of Molecular Sciences, 2016
- NAFLD: A multisystem diseaseJournal of Hepatology, 2015
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysisPLOS Medicine, 2014
- Epidemiology of alcoholic and nonalcoholic fatty liver disease in ChinaJournal of Gastroenterology and Hepatology, 2013
- Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonanceJournal of Hepatology, 2009
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009